GENETIC TESTING COMPANY 23ANDME DECLARES BANKRUPTCY

Summary from the TLDR newsletter

23andMe has entered Chapter 11 bankruptcy and has asked a court to arrange its sale. The company's entire board resigned back in September due to a conflict between its board about future directions - the company has been losing money for years. There is enough funding to continue operations until a buyer is found. The pending sale has raised significant privacy concerns. The US prevents the use of genetic data for use in health insurance and employment decisions, but plenty of other uses are still legal, and customers outside of the US may have far fewer protections.